Refreshing results…
Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study
UploadP17.22 * Lomustin or Bevacizumab at First Recurrence of Glioblastoma
Download from academic.oup.comMissing publications? Search for publications with a matching author name.